Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 246 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Incannex Healthcare Inc.), Security Agreement (CDT Equity Inc.), Pre Funded Common Stock Purchase Warrant (Solidion Technology Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 207 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Auddia Inc.), Pre Funded Common Stock Purchase Warrant (Jaguar Health, Inc.), Pre Funded Common Stock Purchase Warrant (Society Pass Incorporated.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 88 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Indaptus Therapeutics, Inc.), Exchange and Settlement Agreement (American Rebel Holdings Inc), Security Agreement (Eloxx Pharmaceuticals, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 43 contracts
Sources: Security Agreement (Cycurion, Inc.), Security Agreement (Vsee Health, Inc.), Prefunded Common Stock Purchase Warrant (Actelis Networks Inc)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.00001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.00001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.00001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 35 contracts
Sources: Pre Funded Common Stock Purchase Warrant (FibroBiologics, Inc.), Pre Funded Common Stock Purchase Warrant (FibroBiologics, Inc.), Pre Funded Common Stock Purchase Warrant (GeoVax Labs, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 26 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Celularity Inc), Security Agreement (Sidus Space Inc.), Security Agreement (Sidus Space Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 26 contracts
Sources: Security Agreement (iBio, Inc.), Pre Funded Warrant Agreement (Soligenix, Inc.), Pre Funded Common Stock Purchase Warrant (Heritage Distilling Holding Company, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 23 contracts
Sources: Pre Funded Ordinary Share Purchase Warrant (China SXT Pharmaceuticals, Inc.), Pre Funded Ordinary Share Purchase Warrant (Lobo Technologies Ltd.), Pre Funded Warrant Agreement (Greenland Technologies Holding Corp.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 21 contracts
Sources: Vendor Agreement (Digital Brands Group, Inc.), Pre Funded Common Stock Purchase Warrant (La Rosa Holdings Corp.), Pre Funded Common Stock Purchase Warrant (La Rosa Holdings Corp.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 16 contracts
Sources: Pre Funded Common Share Purchase Warrant (C3is Inc.), Pre Funded Common Share Purchase Warrant (Imperial Petroleum Inc./Marshall Islands), Pre Funded Common Share Purchase Warrant (Imperial Petroleum Inc./Marshall Islands)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.001, subject to adjustment hereunder (such remaining unpaid exercise price, the “Exercise Price”).
Appears in 16 contracts
Sources: Prefunded Common Stock Purchase Warrant (Rezolute, Inc.), Pre Funded Common Stock Purchase Warrant (Helius Medical Technologies, Inc.), Pre Funded Common Stock Purchase Warrant (Helius Medical Technologies, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 16 contracts
Sources: Placement Agency Agreement (Cel Sci Corp), Pre Funded Common Stock Purchase Warrant (Sonoma Pharmaceuticals, Inc.), Pre Funded Common Stock Purchase Warrant (Sonoma Pharmaceuticals, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 13 contracts
Sources: Pre Funded Ordinary Share Purchase Warrant (Fitness Champs Holdings LTD), Pre Funded Ordinary Share Purchase Warrant (JIADE LTD), Securities Purchase Agreement (JIADE LTD)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 10 contracts
Sources: Pre Funded Warrant Certificate (BriaCell Therapeutics Corp.), Placement Agency Agreement (BriaCell Therapeutics Corp.), Pre Funded Common Shares Purchase Warrant (BriaCell Therapeutics Corp.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (such remaining unpaid exercise price, the “Exercise Price”).
Appears in 9 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Nuvve Holding Corp.), Pre Funded Common Stock Agreement (Surrozen, Inc./De), Prefunded Common Stock Purchase Warrant (Aytu Biopharma, Inc)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person the Company to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 9 contracts
Sources: Securities Agreement (Kiora Pharmaceuticals Inc), Securities Agreement (Kiora Pharmaceuticals Inc), Pre Funded Common Stock Purchase Warrant (iSpecimen Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant ShareADS, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant ShareADS) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock ADS under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 9 contracts
Sources: Pre Funded Warrant (Xylo Technologies LTD), Pre Funded Warrant Agreement (TC BioPharm (Holdings) PLC), Pre Funded Warrant Agreement (SaverOne 2014 Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.01, subject to adjustment hereunder (such remaining unpaid exercise price, the “Exercise Price”).
Appears in 8 contracts
Sources: Warrant Agency Agreement (Fossil Group, Inc.), Warrant Agency Agreement (Fossil Canada, Inc), Prefunded Common Stock Purchase Warrant (Fossil Group, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “"Exercise Price”").
Appears in 8 contracts
Sources: Placement Agency Agreement (Snow Lake Resources Ltd.), Placement Agency Agreement (Snow Lake Resources Ltd.), Placement Agency Agreement (Snow Lake Resources Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant ShareADS, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant ShareADS) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock ADS under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 8 contracts
Sources: Prefunded Ads Purchase Warrant (RedHill Biopharma Ltd.), Prefunded Ads Purchase Warrant (RedHill Biopharma Ltd.), Security Agreement (Steakholder Foods Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person the Company to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 8 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Shuttle Pharmaceuticals Holdings, Inc.), Pre Funded Ordinary Share Purchase Warrant (Mixed Martial Arts Group LTD), Pre Funded Common Stock Purchase Warrant (Shuttle Pharmaceuticals Holdings, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 8 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Datacentrex, Inc.), Pre Funded Common Stock Purchase Warrant (Transcode Therapeutics, Inc.), Warrant Agreement (MAIA Biotechnology, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Exercisability Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect affect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price Exercise Price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 7 contracts
Sources: Security Agreement (Sonnet BioTherapeutics Holdings, Inc.), Securities Purchase Agreement (Sonnet BioTherapeutics Holdings, Inc.), Securities Purchase Agreement (Sonnet BioTherapeutics Holdings, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant ShareShare (the “Aggregate Exercise Price”), was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such the pre-paid aggregate exercise price Aggregate Exercise Price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 7 contracts
Sources: Warrant Agreement (OceanPal Inc.), Pre Funded Common Share Purchase Warrant (OceanPal Inc.), Pre Funded Common Share Purchase Warrant (OceanPal Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant Share shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 7 contracts
Sources: Pre Funded Common Stock Purchase Warrant (InspireMD, Inc.), Pre Funded Common Stock Purchase Warrant (CNS Pharmaceuticals, Inc.), Pre Funded Common Stock Purchase Warrant (ShiftPixy, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant ShareWarrant, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant ShareWarrant) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 7 contracts
Sources: Security Agreement (InMed Pharmaceuticals Inc.), Security Agreement (InMed Pharmaceuticals Inc.), Securities Agreement (InMed Pharmaceuticals Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 7 contracts
Sources: Warrant Agreement (electroCore, Inc.), Warrant Agreement (electroCore, Inc.), Security Agreement (Reliance Global Group, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 US$0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 US$0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.0001US$0.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 7 contracts
Sources: Pre Funded Ordinary Share Purchase Warrant (Chijet Motor Company, Inc.), Pre Funded Ordinary Share Purchase Warrant (Chijet Motor Company, Inc.), Pre Funded Class a Ordinary Share Purchase Warrant (Lichen China LTD)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 7 contracts
Sources: Security Agreement (Clearmind Medicine Inc.), Security Agreement (Psyence Biomedical Ltd.), Pre Funded Common Share Purchase Warrant (BriaCell Therapeutics Corp.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.0002 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issuance Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.0002 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.00010.0002, subject to adjustment hereunder (the “Exercise Price”).
Appears in 6 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Scorpius Holdings, Inc.), Pre Funded Common Stock Purchase Warrant (Scorpius Holdings, Inc.), Pre Funded Common Stock Purchase Warrant (Scorpius Holdings, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant ShareADS, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant ShareADS) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant ADS under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 6 contracts
Sources: Pre Funded Warrant Agreement (Can-Fite BioPharma Ltd.), Pre Funded Warrant Agreement (Can-Fite BioPharma Ltd.), Pre Funded Warrant (Mobilicom LTD)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 6 contracts
Sources: Pre Funded Ordinary Shares Purchase Warrant (ATIF Holdings LTD), Ordinary Share Pre Funded Purchase Warrant (Nabriva Therapeutics PLC), Warrant Agreement (Aptorum Group LTD)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.0001[ ], subject to adjustment hereunder. The remaining unpaid exercise price per Warrant Share shall be $0.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 6 contracts
Sources: Pre Funded Common Stock Purchase Warrant (AIM ImmunoTech Inc.), Pre Funded Common Stock Purchase Warrant (Obalon Therapeutics Inc), Warrant Agency Agreement (Advaxis, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person the Company to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant Share shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 5 contracts
Sources: Warrant Agreement (Soleno Therapeutics Inc), Prefunded Common Stock Purchase Warrant (Abvc Biopharma, Inc.), Warrant Agent Agreement (Brain Scientific Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001, subject to adjustment hereunder (such remaining unpaid exercise price, the “Exercise Price”).
Appears in 5 contracts
Sources: Prefunded Common Share Purchase Warrant (Neptune Wellness Solutions Inc.), Prefunded Common Share Purchase Warrant (Neptune Wellness Solutions Inc.), Prefunded Common Share Purchase Warrant (Neptune Wellness Solutions Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.00001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.00001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.00010.00001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 5 contracts
Sources: Security Agreement (Pluri Inc.), Security Agreement (Pluri Inc.), Pre Funded Common Shares Purchase Warrant (Virpax Pharmaceuticals, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price Exercise Price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Expiration Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 5 contracts
Sources: Warrant Agreement (Vislink Technologies, Inc.), Warrant Agreement (Vislink Technologies, Inc.), Warrant Agreement (Vislink Technologies, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.001, subject to adjustment hereunder (such remaining unpaid exercise price, the “Exercise Price”).
Appears in 4 contracts
Sources: Common Stock Purchase Warrant (T Stamp Inc), Common Stock Purchase Warrant (T Stamp Inc), Common Stock Purchase Warrant (T Stamp Inc)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $US$0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $US$0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001, US$0.0001 (subject to adjustment hereunder (hereunder, the “"Exercise Price”").
Appears in 4 contracts
Sources: Security Agreement (Flora Growth Corp.), Securities Purchase Agreement (Flora Growth Corp.), Securities Purchase Agreement (Flora Growth Corp.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 4 contracts
Sources: Pre Funded Order Agreement (Meten Holding Group Ltd.), Pre Funded Ordinary Share Purchase Warrant (Meten Holding Group Ltd.), Pre Funded Ordinary Share Purchase Warrant (Greenland Technologies Holding Corp.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 CAD$0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 CAD$0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001CAD$0.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 4 contracts
Sources: Placement Agency Agreement (Vision Marine Technologies Inc.), Securities Purchase Agreement (DEFSEC Technologies Inc.), Placement Agency Agreement (Vision Marine Technologies Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 4 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Biovie Inc.), Pre Funded Common Stock Purchase Warrant (Biovie Inc.), Common Stock Purchase Warrant (Biovie Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $US$0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $US$0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001, US$0.0001 (subject to adjustment hereunder (hereunder, the “"Exercise Price”").
Appears in 3 contracts
Sources: Securities Contribution Agreement (ZeroStack Corp.), Share Exchange Agreement (ZeroStack Corp.), Security Agreement (ZeroStack Corp.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person the Company to effect any exercise of this Warrant. The Holder shall Shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant Share shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Presidio Property Trust, Inc.), Pre Funded Common Stock Purchase Warrant (Eyenovia, Inc.), Pre Funded Common Stock Purchase Warrant (Eyenovia, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 CHF 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 CHF 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Shares under this Warrant shall be $0.0001CHF 0.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Underwriting Agreement (Altamira Therapeutics Ltd.), Pre Funded Common Share Purchase Warrant (Altamira Therapeutics Ltd.), Underwriting Agreement (Altamira Therapeutics Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 CA$0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 CA$0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001CA$0.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Underwriting Agreement (Vision Marine Technologies Inc.), Pre Funded Common Shares Purchase Warrant (Vision Marine Technologies Inc.), Underwriting Agreement (Vision Marine Technologies Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant Share shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Nuburu, Inc.), Pre Funded Common Share Purchase Warrant (XORTX Therapeutics Inc.), Pre Funded Common Share Purchase Warrant (XORTX Therapeutics Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant ShareADS, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant ShareADS) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant ADS under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Security Agreement (Kazia Therapeutics LTD), Pre Funded Warrant Agreement (Quoin Pharmaceuticals, Ltd.), Common Stock Pre Funded Purchase Warrant (UpHealth, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person the Company to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of the Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Security Agreement (DarioHealth Corp.), Security Agreement (DarioHealth Corp.), Prefunded Common Stock Purchase Warrant (DarioHealth Corp.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant ShareADS, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant ShareADS) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant ADS under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Security Agreement (Addex Therapeutics Ltd.), Security Agreement (Addex Therapeutics Ltd.), Security Agreement (Addex Therapeutics Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever[, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Azitra, Inc.), Warrant Agreement (Ensysce Biosciences, Inc.), Prefunded Common Stock Purchase Warrant (Ensysce Biosciences, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price Exercise Price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Warrant Agreement (Brickell Biotech, Inc.), Warrant Agreement (Brickell Biotech, Inc.), Warrant Agreement (Digital Ally Inc)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.007 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.007 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.007, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Pre Funded Common Stock Purchase Warrant (bioAffinity Technologies, Inc.), Pre Funded Common Stock Purchase Warrant (bioAffinity Technologies, Inc.), Pre Funded Common Stock Purchase Warrant (bioAffinity Technologies, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.17, subject to adjustment hereunder. The remaining unpaid exercise price per Warrant Share under this Warrant shall be $0.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Warrant Agreement (Cesca Therapeutics Inc.), Securities Purchase Agreement (Cesca Therapeutics Inc.), Warrant Agreement (Cesca Therapeutics Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Underwriting Agreement (Permex Petroleum Corp), Pre Funded Common Share Purchase Warrant (Foremost Lithium Resource & Technology Ltd.), Underwriting Agreement (KWESST Micro Systems Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Class A Ordinary Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Securities Purchase Agreement (Webuy Global LTD), Securities Purchase Agreement (Webuy Global LTD), Security Agreement (Skyline Builders Group Holding LTD)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, 0.01 (subject to adjustment hereunder (hereunder, the “Exercise Price”).
Appears in 3 contracts
Sources: Warrant Agency Agreement (1847 Holdings LLC), Warrant Agency Agreement (1847 Holdings LLC), Warrant Agency Agreement (1847 Holdings LLC)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, 0.0001 subject to adjustment hereunder (the “Exercise Price”).
Appears in 3 contracts
Sources: Prefunded Common Stock Purchase Warrant (Bluejay Diagnostics, Inc.), Prefunded Common Stock Purchase Warrant (Bluejay Diagnostics, Inc.), Common Stock Purchase Warrant (Scilex Holding Co)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant Share shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Security Agreement (Opgen Inc), Security Agreement (Opgen Inc)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Shares under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Ordinary Share Purchase Warrant (VCI Global LTD), Pre Funded Ordinary Share Purchase Warrant (VCI Global LTD)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Prefunded Common Share Purchase Warrant (Aeterna Zentaris Inc.), Pre Funded Ordinary Share Purchase Warrant (Intec Pharma Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Shares under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Ordinary Share Purchase Warrant (Wearable Devices Ltd.), Pre Funded Ordinary Share Purchase Warrant (SciSparc Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Common Shares Purchase Warrant (Performance Shipping Inc.), Warrant Agreement (Performance Shipping Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issuance Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Dateexercised. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Warrant Agreement (Haoxi Health Technology LTD), Pre Funded Warrant (Haoxi Health Technology LTD)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.0001, subject to adjustment hereunder 0.0001 (the “Exercise Price”).
Appears in 2 contracts
Sources: Security Agreement (Virax Biolabs Group LTD), Security Agreement (Virax Biolabs Group LTD)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.000001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.000001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per of a share of Common Stock under this Warrant shall be $0.00010.000001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Exchange Agreement (Auto Parts 4Less Group, Inc.), Pre Funded Common Stock Purchase Warrant (Auto Parts 4Less Group, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.0035 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.0035 per Warrant Share) shall be required to be paid by the Holder to any Person person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001, subject to adjustment hereunder 0.0035 (the “Exercise Price”).
Appears in 2 contracts
Sources: Security Agreement (Fusion Fuel Green PLC), Security Agreement (Fusion Fuel Green PLC)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be shall be $0.0001, 0.01 (subject to adjustment hereunder (hereunder, the “Exercise Price”).
Appears in 2 contracts
Sources: Warrant Agreement (1847 Holdings LLC), Warrant Agreement (1847 Holdings LLC)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.0035 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.0035 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001, subject to adjustment hereunder 0.0035 (the “Exercise Price”).
Appears in 2 contracts
Sources: Security Agreement (Fusion Fuel Green PLC), Security Agreement (Fusion Fuel Green PLC)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Warrant Agent Agreement (Applied UV, Inc.), Common Stock Purchase Warrant (XpresSpa Group, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Phio Pharmaceuticals Corp.), Pre Funded Common Stock Purchase Warrant (Phio Pharmaceuticals Corp.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Prefunded Common Stock Purchase Warrant (Aethlon Medical Inc), Prefunded Common Stock Purchase Warrant (Aethlon Medical Inc)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.002 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.002 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.00010.002, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Common Share Purchase Warrant (Altamira Therapeutics Ltd.), Pre Funded Common Share Purchase Warrant (Altamira Therapeutics Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 US$0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 US$0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.0001US$0.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Common Share Purchase Warrant (SRIVARU Holding LTD), Pre Funded Common Share Purchase Warrant (Vision Marine Technologies Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant ShareShare (the “Aggregate Exercise Price”), was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such the pre-paid aggregate exercise price Aggregate Exercise Price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Warrant Agreement (United Maritime Corp), Pre Funded Common Share Purchase Warrant (United Maritime Corp)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Common Share Purchase Warrant (Aptose Biosciences Inc.), Security Agreement (Establishment Labs Holdings Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Sidus Space Inc.), Pre Funded Common Stock Purchase Warrant (Sidus Space Inc.)
Exercise Price. The aggregate exercise price of this Series A Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issuance Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Expiration Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Common Stock Purchase Warrant (Brickell Biotech, Inc.), Common Stock Purchase Warrant (Brickell Biotech, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Warrant Agreement (ReWalk Robotics Ltd.), Warrant Agreement (ReWalk Robotics Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.0001[ ], subject to adjustment hereunder. The remaining unpaid exercise price per Warrant Share shall be $0.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Onconova Therapeutics, Inc.), Pre Funded Common Stock Purchase Warrant (Heat Biologics, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant ShareWarrant, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant ShareWarrant) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Histogen Inc.), Pre Funded Common Stock Purchase Warrant (Histogen Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal an exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Warrant Agreement (Iterum Therapeutics PLC), Pre Funded Ordinary Share Purchase Warrant (Iterum Therapeutics PLC)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Underwriting Agreement (Cel Sci Corp), Pre Funded Common Stock Purchase Warrant (Cel Sci Corp)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person the Company to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant Share shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Ordinary Security Agreement (NeuroSense Therapeutics Ltd.), Pre Funded Ordinary Shares Purchase Warrant (NeuroSense Therapeutics Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event . The exercise price per Warrant Share under this Warrant shall not have been exercised prior be $____, subject to the Termination Dateadjustment hereunder. The remaining unpaid exercise price per share of Common Stock Warrant Share under this Warrant shall be $0.0001, 0.001 subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Warrant Agreement (Diffusion Pharmaceuticals Inc.), Pre Funded Common Stock Purchase Warrant (Diffusion Pharmaceuticals Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Warrant Agreement (First Wave BioPharma, Inc.), Warrant Agreement (AzurRx BioPharma, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 NIS 0.30 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 NIS 0.30 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.0001NIS 0.30, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Securities Purchase Agreement (Brenmiller Energy Ltd.), Securities Purchase Agreement (Brenmiller Energy Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant ShareADS, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant ShareADS) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock ADS under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Warrant Agent Agreement (Cellect Biotechnology Ltd.), Pre Funded Warrant (Medigus Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $US$0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $US$0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $US$0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 2 contracts
Sources: Pre Funded Common Stock Purchase Agreement (Acasti Pharma Inc.), Pre Funded Common Share Purchase Warrant (Titan Medical Inc)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $US$0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $US$0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, US$0.0001 (subject to adjustment hereunder (hereunder, the “Exercise Price”).
Appears in 2 contracts
Sources: Security Agreement (Firefly Neuroscience, Inc.), Security Agreement (Firefly Neuroscience, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 US$0.00001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 US$0.00001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.0001US$0.00001, subject to adjustment hereunder (such remaining unpaid exercise price, the “Exercise Price”)..
Appears in 1 contract
Exercise Price. The aggregate exercise price of this WarrantWarrant is $[—-] per share, except for a nominal exercise price all of $0.0001 per Warrant Share, which was pre-funded to the Company on or prior to the Initial Exercise Date except for a nominal exercise price of $0.0001 per Warrant Share, and, consequently, no additional consideration (other than the nominal remaining exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Datein full. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Remaining Exercise Price”).
Appears in 1 contract
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 US$0.0005 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 US$0.0005 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.0001US$0.0005, subject to adjustment hereunder (the “Exercise Price”).
Appears in 1 contract
Sources: Pre Funded Ordinary Share Purchase Warrant (WORK Medical Technology Group LTD)
Exercise Price. The aggregate exercise price Exercise Price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant ShareADS, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant ShareADS) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price Exercise Price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock ADS under this Warrant shall be $0.0001[ ]1, subject to adjustment hereunder (the “Exercise Price”).
Appears in 1 contract
Sources: Warrant Agreement (Medigus Ltd.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Exercisability Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price Exercise Price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 1 contract
Sources: Underwriting Agreement (Sonnet BioTherapeutics Holdings, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled 192275006 v2 to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”).
Appears in 1 contract
Sources: Pre Funded Common Stock Purchase Warrant (Biocept Inc)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person the Company to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Ordinary Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 1 contract
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 [0.001] per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 [0.001] per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001[0.001], subject to adjustment hereunder (the “Exercise Price”).
Appears in 1 contract
Sources: Common Stock Purchase Warrant (Plus Therapeutics, Inc.)
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Issue Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Share under this Warrant shall be $0.00010.01, subject to adjustment hereunder (the “Exercise Price”“).
Appears in 1 contract
Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant ShareWarrant, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant ShareWarrant) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per share of Common Stock Warrant under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).
Appears in 1 contract
Sources: Pre Funded Warrant Agreement (AnPac Bio-Medical Science Co., Ltd.)